FDA Inspection
ACME GENERICS PRIVATE LIMITEDACME GENERICS PRIVATE LIMITED – FDA Inspection, Feb 20, 2026
Record Details
This FDA Inspection record concerns ACME GENERICS PRIVATE LIMITED, with an inspection on February 20, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 98e042e8-cbe9-4c79-a7a6-7501588b537e
Inspection Facts
- Inspection number
- 1305200
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ACME GENERICS PRIVATE LIMITED
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 2, 2023 | Not classified | Office of Inspections and Investigations |
Other documents for ACME GENERICS PRIVATE LIMITED
- FDA Inspection 1209940 - 2023-06-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.